A double-blind, placebo-controlled, randomised, parallel-group, dose-escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 suppositories for 14 days.
Colorectal Dis
; 16 Suppl 1: 36-50, 2014 Mar.
Article
em En
| MEDLINE
| ID: mdl-24499495
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Agonistas de Receptores Adrenérgicos alfa 1
/
Metoxamina
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article